Generate data that addresses unmet needs in diabetes and obesity: Generate data that addresses unmet needs in diabetes and obesity: Generating compelling data on comorbidities of diabetes and obesity, including cardiovascular and kidney outcomes, is critical to effectively competing with incumbents
2.4% placebo (N=1,961) SURMOUNT-1 mean weight loss / 20.9% body-weight reduction at 72 weeks with tirzepatide 15 mg vs
Mean HDL-C was 37.5 mg/dL and abnormal in 43.5% of patients (30)
Haas sit down with Joe Brown financial educator, YouTuber, and founder of Heresy Financial to talk about his transformation from obese to ripped, his peptide journey, Hashimoto's diagnosis, high SHBG struggles, and what finance and fitness have in common
Semaglutide remains FDA-approved with an extensive real-world safety record
17 In the initial literature, two thirds of the subjects reported symptoms of MCA, including urticaria, flushing, asthma, anaphylaxis, and episodic GI distress
